Science Sparks @ ACTREC
3 November 2025Vol. No. 14; Issue No. 707
Publications
- 1. Chaturvedi P, Darling HS, Govind BK, Noronha V, Kuriakose M, Birur P, Kaushal A, Mahajan A, Singhal M, Gairola M, Goyal S, Patil VM, Rao V, Rath G, Prabhash K (2025). Indian clinical practice consensus guidelines for the management of oral cavity cancer – Update 2024.Cancer Research, Statistics, and Treatment. 8 (suppl.1):S1-S5.
- 2. Darling HS, Govind BK, Noronha V, Chaturvedi P, Kuriakose M, Birur P, Kaushal A, Mahajan A, Singhal M, Gairola M, Goyal S, Patil V, Rao V, Rath G, Prabhash K (2025). Indian clinical practice consensus guidelines for the management of locoregional hypopharyngeal cancer – Update 2024. Cancer Research, Statistics and Treatment. 8(Suppl 1):p S6-S9.
- 3. Noronha V, Govind BK, Darling HS, Chaturvedi P, Kuriakose M, Birur P, Kaushal A, Mahajan A, Singhal M, Gairola M, Goyal S, Patil V, Rao V, Rath G, Prabhash K(2025). Indian clinical practice consensus guidelines for the management of oropharyngeal cancer – Update 2024. Cancer Research, Statistics and Treatment 8(Suppl 1):p S10-S15.
- 4. Singhal M, Govind BK, Darling HS, Chaturvedi P, Kuriakose M, Birur P, Kaushal A, Mahajan A, Gairola M, Goyal S, Patil V, Noronha V, Rao V, Rath G, Prabhash K (2025). Indian clinical practice consensus guidelines for the management of locoregional laryngeal cancer – Update 2024. Cancer Research, Statistics and Treatment. 8(Suppl 1):p S16-S20.
- 5. Darling HS, Noronha V, Govind Bk, Chaturvedi P, Kuriakose M, Birur P, Kaushal A, Mahajan A, Singhal M, Gairola M, Goyal S, Patil V, Rao V, Rath G, Prabhash K (2025). Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer – Update 2024. Cancer Research, Statistics and Treatment 8(Suppl 1):p S21-S25.
- 6. Noronha V, Govind BK, Darling HS, Chaturvedi P, Kuriakose M, Mahajan A, Birur P, Kaushal A, Singhal M, Gairola M, Goyal S, Patil V, Rao V, Rath G, Prabhash K( 2025). Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2024. Cancer Research, Statistics and Treatment 8(Suppl 1):p S26-S31.
- 7. Vijan A, Nair SM, Sahu A, Chopade P, Sridhar E, Jain A, Chatterjee A, Choudhari A, Prasad M, Chinnaswamy G, Singh V, Shetty P, Dasgupta A, Moiyadi A, Gupta T, Goda JS(2025). High-grade gliomas associated with neurofibromatosis type 1: analysis of imaging features and literature review. Polish Journal of Radiology.
- 8. Puranik AD, Dev ID, Yadav S, Rangarajan V, Agrawal A, Basu S, Chaudhari VA, Ramaswamy A, Ostwal V, Bhandare MS, Shrikhande SV, Parghane RV, Bhargava P, Bal MM, Yadav S, Patkar S, Goel M, Purandare NC, Shah S, Choudhury S, Ghosh S, Venkatachalam M. PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs). BMC Cancer.25(1):1659.
- 9. Hingorani L, Karmakar M, Mukherjee S, Modi SJ, Mulay V, Gota V (2025). A bibliometric and critical trend analysis of the anti-cancer potential of Withania somnifera during 2000-2024. Naunyn-Schmiedeberg's Archives of Pharmacology.
- 10. Singh A, Gupta I, Saha P, Hole A, Anthony F, Natu A, Smoot AT, Ashktorab H, CM Krishna, Gupta S(2025). Raman spectroscopy for detecting gastric and liver cancer cells that entered a tolerant persistence state to survive cisplatin chemotherapy. Biochemical and Biophysical Research Communications
- 11. Kuthe SM, Bandyopadhyay V, Aparnavi P, Venkatesh U, Padhi BK, Gandhi AP (2025). Electronic cigarettes (ENDS OR ENNDS) smoking in Asian Countries after complete vaping Ban: A systematic review and meta-analysis. Substance Use and Misuse.
- 12. Punatar S, Jindal N, Gokarn A, Mirgh S, Chichra A, Nayak L, Bagal B, Subramanian P, Tembhare P, Patkar N, Chatterjee G, Rajpal S, Kannan S, Hande V, Kumbhalwar K, Chavan S, Menon H, Khattry N(2025). Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India. Blood Cancer Journal. 15(1):186.
- 13. Nayak P, Chopra S, Gupta Y, Saahil W, Mittal P, Gupta A, Panda S, Popat P, Gupta S, Agarwal JP, Goda JS (2025). Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer. Brachytherapy.
Video of the Week
Overview of Next Generation Sequencing in Oncology Diagnostics
Upcoming Events
All About Spotting an Invention and Technology Commercialization
November 4, 2025
At Seminar Room, RRU 7th floor, ACTREC, Tata Memorial Centre, Navi Mumbai.
14th In Vivo Preclinical Imaging and Drug Discovery Hands-on Workshop
November 12-14, 2025
At ACTREC, Tata Memorial Centre, Navi Mumbai.
Do You Know?
In 1979, Researcher found the first cancer causing gene, an oncogene in human bladder cancer.
Cancer News
New Kharghar centre provides shelter and care for children undergoing cancer treatment
Free Press Journal, 01/11/2025
Located within the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), part of the Tata Memorial Centre, the facility marks a significant step forward in providing holistic support to vulnerable families. The residential centres go beyond providing shelter, offering nutritious meals,...
AI tool identifies women at high risk of interval breast cancer
RSNA, 28/10/2025
The study cohort included 134,217 screening mammograms on the same number of women (aged 50-70), with 524 interval cancers. The exams were performed between 2014 and 2016 at two U.K. triennial Breast Screening Program centers using two different mammography systems...
Scientists discover COVID mRNA vaccines boost cancer survival
Sciencedaily, 28/10/2025
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)